[ad_1] PenderFund Capital Management Ltd. a réduit de 3,5% sa participation dans Tripadvisor Inc (NASDAQ: TRIP) au troisième trimestre, selon son dernier dépôt auprès de la Securities & Exchange Commission. Le fonds …
Read More »Schwab Charles Investment Management Inc. Boosts Stake in Applied Optoelectronics Inc. (NASDAQ: AAOI)
[ad_1] Schwab Charles Investment Management Inc. lifted its position in Applied Optoelectronics Inc. (NASDAQ: AAOI) by 11.6% during the second quarter, according to the company's most recent filing with the SEC. The …
Read More »Cleveland Research réitère le maintien de la note attribuée à Henry Schein (NASDAQ: HSIC)
[ad_1] Cleveland Research a réédité sa note de détention sur les actions de Henry Schein (NASDAQ: HSIC) dans une note de recherche remise aux investisseurs le lundi 24 septembre. HSIC a fait …
Read More »Is Trinity Biotech plc (NASDAQ: TRIB) attractive at $ 4.73?
[ad_1] I'm going to take a look at some key financial data and some price indicators so potential investors can badess where Trinity Biotech plc (NASDAQ: TRIB) might go. Trinity Biotech plc …
Read More »Retail Analysts with Profitability Analysis: Adient plc (NYSE: ADNT) – NASDAQ Times
[ad_1] Adient plc (NYSE: ADNT) increased 5.75% to $ 47.07. Foreseeing individual factors, the company is in a contradictory position. To reduce the amount of noise on the price chart, the company …
Read More »Zacks investment search upgrades icon (NASDAQ: ICLR) to buy
[ad_1]
Read More »Jazz reports late-stage trial for Vyxeos in blood cancer meets the goal – Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ)
[ad_1] Jazz Pharmaceuticals (NASDAQ: JAZZ) 2.9% falls in after-hours trading after reporting results of a late-stage trial of liposome Vyxeos for injections in two kinds of blood cancer. The study 309 patients …
Read More »Traveling Advance Gene Therapy for Parkinson's Disease, Phase 2 Data May Be Sufficient for Marketing Application in the United States – Voyager Therapeutics (NASDAQ: VYGR)
[ad_1] Based on FDA comments, Voyager Therapeutics (NASDAQ: VYGR) says it is maintaining its plan to submit a BLA seeking approval for VY-AADC gene therapy based on live data 2. He says …
Read More »What is ahead for Presbia Plc – Ordinary Shares (NASDAQ: LENS) after the shorter shares?
[ad_1] <! – Market News -> July 7, 2018 – By Dolores Ford Investor sentiment rose to Infinity in Q1 2018. Its up Infinity, from 0.67 in 2017Q4. It is positive because …
Read More »Donegal Mutual Insurance Co (Nasdaq: DGICB) The index of the confidence of the major currencies collapsed in 2018 from Q1 to T0
[ad_1] <! – Market News -> July 1, 2018 – By Darrel Chase Positions "Big money" "The feeling of money for Donegal Mutual Insurance Co (NASDAQ: DGICB) in 2018 Q1 decreased to …
Read More »